Home RxNorm 2719216 Fluzone 2025-2026 trivalent vaccine Injectable Suspension Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2719216
RxNorm name Fluzone 2025-2026 trivalent vaccine Injectable Suspension
Display name Fluzone 2025-2026 trivalent vaccine Injectable Suspension
Full name Fluzone 2025-2026 trivalent vaccine Injectable Suspension
Term type SY
Status DailyMed mapping
Updated 2026-06-04 23:39:00 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103914 Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent Influenza Virus Vaccine 351(a) Rx 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 5fe0ce14-bc11-4b43-b002-7efdca0d3003 Fluzone 2025-2026 trivalent vaccine Injectable Suspension [PSN] · influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2025-2026] [SBD] · Fluzone 2025-2026 trivalent vaccine Injectable Suspension [SY] 3 12 These highlights do not include all the information needed to use Fluzone® safely and effectively. See full prescribing information for Fluzone. Fluzone (Influenza Vaccine) injectable suspension, for intramuscular use 2025–2026 Formula Initial U.S. Approval: 1980 20260325